Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk

Atherosclerosis and atherosclerotic-related cardiovascular diseases (ASCVD) are characterized by high serum levels of low-density lipoprotein cholesterol (LDL-C) that can promote the generation of reactive oxygen species (ROS). To answer the need for better LDL-C control in individuals at high and v...

Descrición completa

Detalles Bibliográficos

Principais autores:	Alessia Silla, Federica Fogacci, Angela Punzo, Silvana Hrelia, Patrizia Simoni, Cristiana Caliceti, Arrigo F. G. Cicero
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-02-01
Series:	Antioxidants
Assuntos:	Evolocumab PCSK9 inhibitor lipid-lowering treatment PBMC<sub>S</sub> H<sub>2</sub>O<sub>2</sub> chemiluminescence
Acceso en liña:	https://www.mdpi.com/2076-3921/12/3/578
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!